Eton Pharmaceuticals Inc (NAS:ETON)
$ 3.62 -0.08 (-2.16%) Market Cap: 93.00 Mil Enterprise Value: 82.65 Mil PE Ratio: 91.75 PB Ratio: 6.09 GF Score: 58/100

Q2 2020 Eton Pharmaceuticals Inc Earnings Call Transcript

Aug 12, 2020 / 08:30PM GMT
Release Date Price: $6.38 (-6.93%)
Operator

Good afternoon, and welcome to Eton Pharmaceuticals' second-quarter 2020 financial and operating results conference call. (Operator Instructions) Please be advised that this call is being recorded at the company's request.

At this time, I'd like to turn the call over to David Krempa, Vice President of Business Development at Eton Pharmaceuticals. Please proceed.

David Krempa
Eton Pharmaceuticals, Inc. - VP, Business Development

Thank you, operator. Good afternoon, everyone, and welcome to Eton's second-quarter 2020 conference call. This afternoon, we issued a press release that outlines the topics we plan to discuss on today's call. The release is available on our website, etonpharma.com.

Joining me on our call today, we have Sean Brynjelsen, our CEO; Wilson Troutman, our CFO; and Paul Stickler, our Senior Vice President of Sales and Marketing.

Before we begin, I would like to remind everyone that statements made during this call may contain [forward-looking] statements and involve risks and uncertainties that could cause actual

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot